ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 179 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $128 | -37.3% | 40,325 | -1.8% | 0.01% | -37.5% |
| Q2 2023 | $204 | +7.4% | 41,061 | +6.8% | 0.02% | +14.3% |
| Q1 2023 | $190 | -23.7% | 38,437 | -3.0% | 0.01% | -33.3% |
| Q4 2022 | $249 | -99.9% | 39,645 | +25.4% | 0.02% | -34.4% |
| Q3 2022 | $341,000 | +19.6% | 31,608 | +26.4% | 0.03% | +23.1% |
| Q2 2022 | $285,000 | +10.5% | 25,006 | -11.7% | 0.03% | +225.0% |
| Q1 2022 | $258,000 | – | 28,315 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
| Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
| TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
| EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
| CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
| Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
| CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
| Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
| Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
| Navalign, LLC | 75,365 | $238,907 | 0.09% |